Mario Stylianou

7.3k total citations
81 papers, 3.9k citations indexed

About

Mario Stylianou is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mario Stylianou has authored 81 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 26 papers in Pulmonary and Respiratory Medicine and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mario Stylianou's work include Tuberous Sclerosis Complex Research (26 papers), Congenital Heart Disease Studies (11 papers) and Eosinophilic Disorders and Syndromes (10 papers). Mario Stylianou is often cited by papers focused on Tuberous Sclerosis Complex Research (26 papers), Congenital Heart Disease Studies (11 papers) and Eosinophilic Disorders and Syndromes (10 papers). Mario Stylianou collaborates with scholars based in United States, Canada and Italy. Mario Stylianou's co-authors include Joel Moss, Angelo M. Taveira‐DaSilva, Nancy Flournoy, Nathan L. Pace, David C. Warltier, Olanda Hathaway, Lynn A. Sleeper, Nilo A. Avila, Lynn Mahony and Andrew M. Atz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Annals of Internal Medicine.

In The Last Decade

Mario Stylianou

78 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Stylianou United States 32 1.3k 1.3k 1.1k 848 844 81 3.9k
Khaled M. Musallam Lebanon 42 603 0.5× 515 0.4× 714 0.7× 558 0.7× 336 0.4× 173 6.7k
Rudi M. H. Roumen Netherlands 47 663 0.5× 1.0k 0.8× 3.2k 3.0× 603 0.7× 626 0.7× 223 7.1k
Nestor F. Esnaola United States 31 214 0.2× 654 0.5× 1.5k 1.4× 812 1.0× 420 0.5× 88 3.8k
Philippe Le Toumelin France 21 703 0.5× 1.4k 1.1× 312 0.3× 187 0.2× 213 0.3× 39 2.4k
Mark J. Krasna United States 44 530 0.4× 4.7k 3.8× 3.6k 3.4× 248 0.3× 188 0.2× 181 7.1k
Jacques Boddaert France 28 303 0.2× 350 0.3× 779 0.7× 784 0.9× 375 0.4× 96 3.2k
Fergal J. Fleming United States 43 283 0.2× 781 0.6× 2.9k 2.7× 893 1.1× 283 0.3× 195 5.2k
Peter W. Collins United Kingdom 60 543 0.4× 649 0.5× 879 0.8× 638 0.8× 405 0.5× 252 11.9k
Tosiya Sato Japan 31 215 0.2× 585 0.5× 718 0.7× 398 0.5× 762 0.9× 147 3.6k
Robin H. Kennedy United Kingdom 36 955 0.7× 1.1k 0.9× 4.2k 3.9× 2.5k 3.0× 125 0.1× 96 5.7k

Countries citing papers authored by Mario Stylianou

Since Specialization
Citations

This map shows the geographic impact of Mario Stylianou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Stylianou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Stylianou more than expected).

Fields of papers citing papers by Mario Stylianou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Stylianou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Stylianou. The network helps show where Mario Stylianou may publish in the future.

Co-authorship network of co-authors of Mario Stylianou

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Stylianou. A scholar is included among the top collaborators of Mario Stylianou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Stylianou. Mario Stylianou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voukkali, Irene, et al.. (2023). The city of tomorrow: Challenges and Solutions. A case study of a coastal town.. IOP Conference Series Earth and Environmental Science. 1196(1). 12073–12073.
2.
Steagall, Wendy K., Mario Stylianou, Gustavo Pacheco–Rodriguez, Zu Xi Yu, & Joel Moss. (2023). Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis. ERJ Open Research. 9(4). 305–2023. 1 indexed citations
3.
Cui, Ye, Wendy K. Steagall, Gustavo Pacheco–Rodriguez, et al.. (2017). Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. Cancer Research. 77(6). 1492–1502. 15 indexed citations
4.
Yao, Jianhua, Angelo M. Taveira‐DaSilva, Amanda M. Jones, et al.. (2014). Sustained Effects of Sirolimus on Lung Function and Cystic Lung Lesions in Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 190(11). 1273–1282. 65 indexed citations
5.
Lamas, Gervasio A., Robin Boineau, Christine Goertz, et al.. (2014). Oral High-Dose Multivitamins and Minerals Alone and in Combination with Chelation Therapy for Coronary Disease: A Randomized Clinical Trial. The Journal of Alternative and Complementary Medicine. 20(5). A2–A3. 1 indexed citations
6.
Lewis, Eldrin F., Gervasio A. Lamas, Daniel B. Mark, et al.. (2014). DIFFERENTIAL OUTCOMES WITH CHELATION THERAPY AMONG PATIENTS WITH ANTERIOR VERSUS NON-ANTERIOR MYOCARDIAL INFARCTION: A TACT SUBSTUDY. Journal of the American College of Cardiology. 63(12). A1565–A1565. 2 indexed citations
7.
Kato, Jiro, Jianfeng Zhu, Chengyu Liu, et al.. (2011). ADP-Ribosylarginine Hydrolase Regulates Cell Proliferation and Tumorigenesis. Cancer Research. 71(15). 5327–5335. 40 indexed citations
8.
9.
Hsu, Daphne T., Victor Zak, Lynn Mahony, et al.. (2010). Enalapril in Infants With Single Ventricle. Circulation. 122(4). 333–340. 189 indexed citations
10.
Terasaki, Yasuhiro, Kinnosuke Yahiro, Gustavo Pacheco–Rodriguez, et al.. (2010). Effects of Prolactin on TSC2 -Null Eker Rat Cells and in Pulmonary Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 182(4). 531–539. 13 indexed citations
11.
Hsu, Daphne T., Victor Zak, Lynn Mahony, et al.. (2009). Abstract 1817: Enalapril Does Not Improve Growth or Ventricular Function in Infants With Single Ventricle: A Multicenter Clinical Trial. Circulation. 120.
12.
Silverman, Angela, Marie Russell, Mihriye Mete, et al.. (2009). Stop Atherosclerosis in Native Diabetics Study (SANDS): Baseline Characteristics of the Randomized Cohort. Digital Scholarship - UNLV (University of Nevada Reno). 3(1). 3. 4 indexed citations
13.
Howard, Barbara V., Mary J. Roman, Richard B. Devereux, et al.. (2008). Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial. Obstetrical & Gynecological Survey. 63(8). 512–513. 13 indexed citations
14.
Pace, Nathan L., Mario Stylianou, & David C. Warltier. (2007). Advances in and Limitations of Up-and-down Methodology. Anesthesiology. 107(1). 144–152. 345 indexed citations
15.
Steagall, Wendy K., Connie G. Glasgow, Olanda Hathaway, et al.. (2007). Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(3). L800–L808. 43 indexed citations
16.
Ryu, Jay H., Joel Moss, Gerald J. Beck, et al.. (2005). The NHLBI Lymphangioleiomyomatosis Registry. American Journal of Respiratory and Critical Care Medicine. 173(1). 105–111. 305 indexed citations
17.
Rouhani, Farshid N., et al.. (2005). Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation. Respiratory Medicine. 99(9). 1175–1182. 52 indexed citations
18.
Taveira‐DaSilva, Angelo M., et al.. (2004). Bone Mineral Density in Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 171(1). 61–67. 16 indexed citations
19.
Taveira‐DaSilva, Angelo M., Mario Stylianou, Arnold S. Kristof, et al.. (2003). Maximal Oxygen Uptake and Severity of Disease in Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 168(12). 1427–1431. 60 indexed citations
20.
Taveira‐DaSilva, Angelo M., et al.. (2001). Reversible Airflow Obstruction, Proliferation of Abnormal Smooth Muscle Cells, and Impairment of Gas Exchange as Predictors of Outcome in Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 164(6). 1072–1076. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026